Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Adaptimmune Therapeutics PLC as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 65
- 0 vs. Q1 2025
- Shares held
- 115.6M
- −473.5K (−0.4%) vs. Q1 2025
- Total value
- $27.7M
- +$4.84M (+21.2%) vs. Q1 2025
- New holders
- 11
- 10 more added
- Sold out
- 11
- 18 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $72 |
| Q4 2025 | 10 | $79.7K |
| Q3 2025 | 55 | $5.47M |
| Q2 2025 | 65 | $27.7M |
| Q1 2025 | 67 | $22.9M |
| Q4 2024 | 80 | $67.0M |
| Q3 2024 | 81 | $144.1M |
| Q2 2024 | 76 | $150.0M |
| Q1 2024 | 80 | $256.1M |
| Q4 2023 | 79 | $113.9M |
| Q3 2023 | 79 | $115.7M |
| Q2 2023 | 89 | $133.9M |
| Q1 2023 | 65 | $126.4M |
| Q4 2022 | 69 | $166.3M |
| Q3 2022 | 68 | $122.4M |
| Q2 2022 | 77 | $195.1M |
| Q1 2022 | 80 | $229.2M |
| Q4 2021 | 85 | $425.9M |
| Q3 2021 | 92 | $577.3M |
| Q2 2021 | 82 | $475.7M |
| Q1 2021 | 84 | $623.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $0 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 10 | $2 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 14 | $3 | 0.00% | 00.0% | Unchanged |
| Koesten, Hirschmann & Crabtree, INC. | 47 | $12 | 0.00% | +47 | New |
| Investors Research Corp | 100 | $24 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 153 | $37 | 0.00% | +153 | New |
| Transce3nd, LLC | 175 | $42 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 213 | $51 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 250 | $60 | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 287 | $69 | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 604 | $145 | 0.00% | 00.0% | Unchanged |
| Garde Capital, Inc. | 750 | $180 | 0.00% | +750 | New |
| Raiffeisen Bank International AG | 907 | $218 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 925 | $222 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,534 | $608 | 0.00% | −47,534−94.9% | Reduced |
| V. M. Manning & Co., Inc. | 22,200 | $1.39K | 0.00% | +22,200 | New |
| Rhumbline Advisers | 8,533 | $2.05K | 0.00% | −9,780−53.4% | Reduced |
| Baader Bank INC | 14,935 | $2.21K | 0.00% | +14,935 | New |
| Kornitzer Capital Management Inc | 10,000 | $2.40K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 10,921 | $2.62K | 0.00% | −11,045−50.3% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 10,816 | $2.70K | 0.00% | −16,000−59.7% | Reduced |
| IFG Advisory, LLC | 11,725 | $2.81K | 0.00% | +1,725+17.3% | Added |
| Ausdal Financial Partners, Inc. | 12,476 | $2.99K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 11,173 | $3.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,304 | $3.19K | 0.00% | −193,428−93.6% | Reduced |
| PKS Advisory Services, LLC | 17,000 | $4.08K | 0.00% | +17,000 | New |
| Prosperity Wealth Management, Inc. | 19,763 | $4.74K | 0.00% | −35−0.2% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 20,000 | $4.79K | 0.00% | +20,000 | New |
| JPMorgan Chase & Co | 22,782 | $5.46K | 0.00% | −859,549−97.4% | Reduced |
| Stifel Financial Corp | 23,007 | $5.52K | 0.00% | −3,462−13.1% | Reduced |
| Raymond James Financial Inc | 25,261 | $6.05K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 27,957 | $6.70K | 0.00% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 30,000 | $7.19K | 0.00% | 00.0% | Unchanged |
| Columbia Advisory Partners LLC | 36,730 | $8.80K | 0.01% | +200+0.5% | Added |
| Susquehanna International Group, LLP | 41,785 | $10.0K | 0.00% | +24,441+140.9% | Added |
| Wells Fargo & Company | 48,900 | $11.7K | 0.00% | +8,200+20.1% | Added |
| Northern Trust Corp | 51,333 | $12.3K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 53,186 | $12.8K | 0.00% | 00.0% | Unchanged |
| State of New Jersey Common Pension Fund D | 54,718 | $13.1K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 54,824 | $13.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 62,958 | $15.1K | 0.00% | −949,782−93.8% | Reduced |
| Geode Capital Management, LLC | 67,032 | $16.1K | 0.00% | −42,034−38.5% | Reduced |
| State of Tennessee, Treasury Department | 73,376 | $17.6K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 79,083 | $19.0K | 0.00% | −1,526−1.9% | Reduced |
| XTX Topco Ltd | 80,022 | $19.2K | 0.00% | +80,022 | New |
| Advisor Group Holdings, Inc. | 90,058 | $20.7K | 0.00% | +25,000+38.4% | Added |
| Almitas Capital LLC | 109,054 | $26.1K | 0.01% | +109,054 | New |
| Clear Harbor Asset Management, LLC | 145,400 | $34.9K | 0.00% | −95,325−39.6% | Reduced |
| Key Client Fiduciary Advisors, LLC | 175,555 | $42.1K | 0.02% | +25,405+16.9% | Added |
| BlackRock, Inc. | 179,087 | $42.9K | 0.00% | −4,599−2.5% | Reduced |
| State Street Corp | 426,714 | $102.3K | 0.00% | +5,422+1.3% | Added |
| Rathbone Brothers plc | 432,818 | $103.7K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 464,278 | $111.3K | 0.00% | −1,290,611−73.5% | Reduced |
| Empirical Finance, LLC | 800,000 | $191.8K | 0.01% | +800,000 | New |
| Bank of America Corp | 1,141,713 | $272.9K | 0.00% | −5,300−0.5% | Reduced |
| Renaissance Technologies LLC | 1,882,860 | $451.3K | 0.00% | +69,000+3.8% | Added |
| Acadian Asset Management LLC | 1,964,141 | $459.0K | 0.00% | −254,074−11.5% | Reduced |
| Rock Springs Capital Management LP | 2,483,468 | $595.3K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 4,232,268 | $1.01M | 0.00% | +1,516,321+55.8% | Added |
| MPM Oncology Impact Management LP | 4,411,821 | $1.06M | 0.18% | −482,523−9.9% | Reduced |
| MPM Asset Management LLC | 4,809,677 | $1.15M | 2.66% | −526,038−9.9% | Reduced |
| NEA Management Company, LLC | 17,079,778 | $4.09M | 0.31% | 00.0% | Unchanged |
| Two Seas Capital LP | 22,580,701 | $5.41M | 0.53% | +2,051,016+10.0% | Added |
| Long Focus Capital Management, LLC | 23,756,687 | $5.69M | 0.37% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 27,404,070 | $6.57M | 0.39% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −135,947−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −94,283−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −87,274−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −78,031−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −30,702−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −26,064−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,149−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,113−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −3,023−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |